AbbVie Inc.: UBS raises target price to $275 from $260
ABBV•UBS raised its target price on AbbVie to $275 from $260.
Related News
Fed says household income, wealth and debt stress rose from 2022 to 2025
SPY•
China, EU strike deal to cut Chinese hybrid vehicle exports by over half
FXI•
BofA Global Research raises Novavax price objective to $8 from $7
NVAX•
US consumer sentiment deteriorates further in October
SPY•
Penguin Solutions initiates coverage with buy rating and $100 target price
PENG•